Esperion Therapeutics | Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Amarin USD 20.8M 28K 2025-09
Amgen USD 539M 1000K 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Cipla INR 807.77M 807.43M 2025-09
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 122.26M 145K 2025-12
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 112K 11K 2023-09
Geron USD 638.36M 338K 2025-12
Grifols EUR 679.73M 0 2025-09
Halozyme Therapeutics USD 117.78M 259K 2025-12
Heron Therapeutics USD 1.52M 14K 2024-09
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Merck USD 2.49B 15.79M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.96M 196K 2025-12
United Therapeutics USD 43.64M 740K 2025-12
Vanda Pharmaceuticals USD 58K 0 2024-12


Esperion Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.